VRCA vs VSTM

Verrica Pharmaceuticals Inc. vs Verastem, Inc. — Valuation Comparison 2026

VRCA

Pharmaceutical Preparations
Verrica Pharmaceuticals Inc.
Quality
5.4
out of 10
Value Trap
30
LOW
Price
$5.76
Last close
Models
8/13
Active
VS

VSTM

Pharmaceutical Preparations
Verastem, Inc.
Quality
5.8
out of 10
Value Trap
24
SAFE
Price
$4.33
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType VRCA Fair ValueVRCA Upside VSTM Fair ValueVSTM Upside
Bayesian DCF Intrinsic $1.88 -67.4% $2.16 -50.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.61 -54.7% $2.19 -49.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for VRCA vs VSTM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VRCA vs VSTM — Which Stock Is More Undervalued?

VSTM scores higher with a 5.8/10 quality rating vs VRCA's 5.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Verrica Pharmaceuticals Inc. (VRCA) and Verastem, Inc. (VSTM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VRCA currently trades at $5.76 with a QOC of 5.4/10, while VSTM trades at $4.33 with a QOC of 5.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).